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Does the Alexis wound retractor increase the risk of blood splashes to the eyes? Early closure of a double blinded
randomised controlled trial
Blood splashes to the eye during surgery create a risk to the surgeon and other theatre staﬀ for the transmission of blood-borne infections,
especially HIV and hepatitis B or C [1].
The Alexis wound retractor is commonly used during abdominal surgery. It is a double ring polyurethane retractor, consisting of two plastic rings
joined by a ﬂexible plastic sleeve. It provides eﬀective retraction of the wound and protects the wound from infection [2–9]. However, when the
retractor is removed (by unrolling the outer ring of the retractor), there is a risk that blood droplets are sprayed into the air which may increase the
risk of blood splashes to the surgeon or assistant's eyes.
The purpose of this study was to determine whether the use of the Alexis retractor for abdominal surgery leads to an increased risk of blood
splashes to the surgeon's or assistant's eyes.
This was a double blinded randomised controlled trial on adult patients undergoing surgery requiring an intraperitoneal abdominal incision at
the University Hospital, Geelong (a regional referral hospital in Victoria, Australia).
The operations were randomly assigned to one group where the Alexis retractor was used, and the control group in which it was not. Operative
technique in the two arms was similar.
In both groups, the surgeon and assistant wore transparent visors. An investigator who was blinded to whether the Alexis retractor had been used
counted the number of macroscopic blood spots on the visor (in keeping with previous methodology [10]).
The study was designed to detect an increase in mean blood splashes from 2.5 to 5 per visor, with a standard deviation of 3.6 (from Ogendo et al.
[11]). The required sample size was 44 operations in each arm.
During the study period, the WHO published guidelines recommending routine use of the Alexis retractor for bowel surgery [12], so we decided
that we could no longer ethically randomize patients into the control arm, and closed the trial prematurely. At this time, 25 operations had been
included in the study (twelve in the Alexis group and 13 controls), so 50 visors were studied. A median of zero (range 0–5) blood splashes were
detected in the Alexis group, and zero (range 0–9) in the controls (P= .91).
This is the only study which has attempted to determine whether using the Alexis retractor poses any risk to the surgical team through blood
splashes. Unfortunately the trial was underpowered to deﬁnitely answer that question. However, the number of blood splashes in the Alexis groups
were low (median of zero blood splashes to the masks of surgeons or assistants), so it seems reasonable to conclude that the use of the Alexis retractor
does not add any clinically signiﬁcant risk.
In summary, we could not detect any increased risk of blood splashes to the eyes of surgeons or their assistants from the use of the Alexis
retractor, but the study was underpowered due to early trial closure.
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Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.conctc.2018.01.001.
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